Carolina Nodari

Dr. Carolina Nodari


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
CNCarolina Nodari
Carolina Nodari
RCRodrigo Cayô
Rodrigo Cayô
ASAna Paula Streling
Ana Paula Streling
Felipe Alberto LeiFelipe Alberto Lei
Felipe Alberto Lei
JWJulia Wille
Julia Wille
AGAna Cristina Gales
Ana Cristina Gales
Carbapenem-resistant Acinetobacter baumannii (CRAB) are emerging worldwide. In South America, clinical isolates presenting such a phenotype usually do not belong to the globally distributed international clone 2 (IC2). The majority of these isolates are also resistant to multiple other antimicrobials and are often designated extremely drug-resistant (XDR). The aim of this study was to characterize the resistance mechanisms presented by 18 carbapenem-resistant A. baumannii isolates from five different Brazilian hospitals. Species identification was determined by rpoB sequencing, and antimicrobial susceptibility was determined by broth microdilution. Isolates were submitted to whole genome sequencing using Illumina platform and genetic similarity was determined by PFGE, MLST, and cgMLST. Genome analysis was used to identify intrinsic and acquired resistance determinants, including mutations in the AdeRSABC efflux system and in outer membrane proteins (OMPs). All isolates were identified as A. baumannii and grouped into 4 pulsotypes by PFGE, which belonged to clonal complexes (CC) 15Pas/103Ox (n = 4) and 79Pas/113Ox (n = 14), corresponding to IC4 and IC5, respectively. High MIC values to carbapenems, broad-spectrum cephalosporins, amikacin, and ciprofloxacin were observed in all isolates, while MICs of ampicillin/sulbactam, gentamicin, and tigecycline varied among the isolates. Minocycline was the most active antimicrobial agent tested. Moreover, 12 isolates (66.7%) were considered resistant to polymyxins. Besides intrinsic OXA-51 and ADC variants, all isolates harbored an acquired carbapenem-hydrolyzing class D β-lactamase (CHDL) encoding gene, either blaOXA–23 or blaOXA–72. A diversity of aminoglycoside modifying enzymes and resistance determinants to other antimicrobial classes were found, as well as mutations in gyrA and parC. Non-synonymous mutations have also been identified in the AdeRSABC efflux system and in most OMPs, but they were considered natural polymorphisms. Moreover, resistance to polymyxins among isolates belonging to IC5 were associated to non-synonymous mutations in pmrB, but no known polymyxin resistance mechanism was identified in isolates belonging to IC4. In conclusion, A. baumannii clinical isolates belonging to South America’s major clones present a myriad of antimicrobial resistance determinants. Special attention should be paid to natural polymorphisms observed in each clonal lineage, especially regarding non-synonymous mutations in constitutive genes associated with distinct resistance phenotypes.

30 May 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
Ana Carolina Mello SantosAna Carolina Mello Santos
Ana Carolina Mello Santos
RSRosa M. Silva
Rosa M. Silva
TVTiago B. Valiatti
Tiago B. Valiatti
FSFernanda Fernandes dos Santos
Fernanda Fernandes dos Santos
JNJosé Neto
José Neto
TGTania Tardelli Gomes
Tania Tardelli Gomes
Escherichia coli EC121 is a multidrug-resistant (MDR) strain isolated from a bloodstream infection of an inpatient with persistent gastroenteritis and T-zone lymphoma that died due to septic shock. Despite causing an extraintestinal infection, previous studies showed that it did not have the usual characteristics of an extraintestinal pathogenic E. coli. Instead, it belonged to phylogenetic group B1 and harbored few known virulence genes. To evaluate the pathogenic potential of strain EC121, an extensive genome sequencing and in vitro characterization of various pathogenicity-associated properties were performed. The genomic analysis showed that strain EC121 harbors more than 50 complete virulence genetic clusters. It also displays the capacity to adhere to a variety of epithelial cell lineages and invade T24 bladder cells, as well as the ability to form biofilms on abiotic surfaces, and survive the bactericidal serum complement activity. Additionally, EC121 was shown to be virulent in the Galleria mellonella model. Furthermore, EC121 is an MDR strain harboring 14 antimicrobial resistance genes, including blaCTX-M-2. Completing the scenario, it belongs to serotype O154:H25 and to sequence type 101-B1, which has been epidemiologically linked to extraintestinal infections as well as to antimicrobial resistance spread. This study with E. coli strain EC121 shows that clinical isolates considered opportunistic might be true pathogens that go underestimated.

20 December 2022 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
Felipe Alberto LeiFelipe Alberto Lei
Felipe Alberto Lei
CNCarolina Nodari
Carolina Nodari
ASAna Paula Streling
Ana Paula Streling
FBFrancisco O. Bessa-Neto
Francisco O. Bessa-Neto
ASAndré V. Siqueira
André V. Siqueira
AGAna Cristina Gales
Ana Cristina Gales
Since its first report, the class A Brazilian Klebsiella carbapenemase (BKC) has been detected only among Enterobacterales isolates from Brazilian hospitals. In this study, we characterized a multidrug-resistant Pseudomonas juntendi clinical isolate and identified a 43.3-kb plasmid carrying bla BKC-1 and a class 1 integron (In 1996 ) containing the arr-2 , qnrVC1 , dfrA21 , and aac(6′)-Ib′ gene cassettes.

1 June 2021 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
CNCarolina Nodari
Carolina Nodari
FSFernanda F. Santos
Fernanda F. Santos
MKMariana N.L. Kurihara
Mariana N.L. Kurihara
TVTiago B. Valiatti
Tiago B. Valiatti
RCRodrigo Cayô
Rodrigo Cayô
AGAna Cristina Gales
Ana Cristina Gales

11 April 2023 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
CSCintya Oliveira Souza
Cintya Oliveira Souza
RCRodrigo Cayô
Rodrigo Cayô
KLKarla Valéria B Lima
Karla Valéria B Lima
DBDanielle M Brasiliense
Danielle M Brasiliense
ASAna Paula Streling
Ana Paula Streling
AGAna Cristina Gales
Ana Cristina Gales
To characterize a novel acquired MBL, BIM-1, in a Pseudomonas #2 (subgroup P. guariconensis) strain isolated from the Aurá river located in the Brazilian Amazon hydrographic basin. WGS using an Illumina® MiSeq System was used to characterize the genome of Pseudomonas sp. IEC33019 strain. Southern blotting/hybridization assays were performed to confirm the location of the MBL-encoding gene, blaBIM-1 (Belém Imipenemase). Antimicrobial susceptibility testing, cloning, and biochemical and phenotypic characterization were performed to determine BIM-1 kinetics. The IEC33019 strain showed high resistance rates to β-lactams, ciprofloxacin and aminoglycosides, being susceptible only to polymyxins and susceptible, increased exposure to aztreonam. WGS analysis revealed a novel acquired MBL-encoding gene, blaBIM-1, found as a gene cassette inserted into a class 1 integron (In1326) that also carried qnrVC1 and aadA11e. In1326 was located in a complex transposon, Tn7122, carried by a 52.7 kb conjugative plasmid (pIEC33019) with a toxin/antitoxin system (vapB/vapC). BIM-1 belongs to the molecular subgroup B1 and shares 70.2% and 64.9% similarity with SIM-1 and IMP-1, respectively. Kinetics analysis of BIM-1 showed hydrolytic activity against all β-lactams tested. BIM-1 is a novel acquired MBL encoded by a gene carried by mobile genetic elements, which can be transferred to other Gram-negative bacilli (GNB). Because the IEC33019 strain was recovered from a river impacted by a populous metropolitan region with poor basic sanitation and served by limited potable freshwater, it would be important to establish the role of the BIM-1-producing GNB as nosocomial pathogens and/or as colonizers of the riverside population in this geographical region.

1 April 2017 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
CNCarolina Nodari
Carolina Nodari
MSMarina Siebert
Marina Siebert
UMUrsula da Silveira Matte
Ursula da Silveira Matte
ABAfonso Luís Barth
Afonso Luís Barth
Serratia marcescens is a Gram-negative rod intrinsically resistant to polymyxins and usually associated with wound, respiratory and urinary tract infections. The whole genome of the first GES-5-producing S. marcescens isolated from a Brazilian patient was sequenced using Ion Torrent PGM System. Besides blaGES-5, we were able to identify genes encoding for other β-lactamases, for aminoglycoside modifying enzymes and for an efflux pump to tetracyclines.